US Patent 7615230 Method for decreasing sebum production
Patent 7615230 was granted and assigned to Graceway Pharmaceuticals on November, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+303 characters)
Article
Patent abstract
The present invention is directed to the topical application of the malonamide ACAT inhibitors described by Formula I. Other aspects of the invention are directed to topical formulations of these diamides, their use to treat sebaceous gland disorders and their use to alleviate oily skin.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07615230 Method for decreasing sebum production US Patent 7615230 Method for decreasing sebum production
Infobox
Patent Number
0761523000
Patent Number
761523000
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076152300
Date of Patent
November 10, 2009
0Patent Application Number
109583060
Date Filed
October 5, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076152300
Date of Patent
November 10, 2009
0Patent Application Number
109583060
Date Filed
October 5, 2004
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07615230 Method for decreasing sebum production
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07615230
Date of patent
November 10, 2009
Patent application number
10958306
Date Filed
October 5, 2004
Patent primary examiner
Find more entities like US Patent 7615230 Method for decreasing sebum production
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.